Lab Views Newsletter April 2008
Introducing ACT's new enewsletter, Lab Views, which will bring you news specific to the laboratory and its uses in clinical trials including deals, alliances, business developments, people news and events.
Bio-Imaging Technologies Buys Phoenix Data Systems
Bio-Imaging Technologies, a provider of medical image management for the clinical trials industry, acquired Phoenix Data Systems, an EDC and eClinical data solutions provider, the end of last month.
>>MORE
Top 3 Clinical Trial Specimen Shipping Concerns
QuickSTAT, a shipping and logistics company specializing in time and temperature critical transportation for the pharmaceutical and biotech industry, gave LabViews the following insight into shipping lab specimens for clinical trials: 1) Protecting specimen integrity 2) Advisory communications 3) Cost.
>>MORE
eRT, PHT, ICON Partner for Oncology Seminar
Northern and Southern California will play host to eResearch Technology's "Partnering in Oncology: Data to Power Decisions" on May 12 and May 13 in Burlingame and La Jolla, respectively. Topics include Imaging in Oncology Trials; Partnering with a CRO in Oncology Trials; and a panel discussion. Speakers include Kenneth A. Getz, MBA, Senior Research Fellow at the Tufts Center for the Study of Drug Development.
>>MORE
WorldCare Clinical
Work with the imaging CRO that is conducting clinical trials in perfect harmony and benefit from clean datasets delivered quickly and cost effectively.
PACS's Lab Information Management Systems (LIMS)
May 10–12 , 2008
Location | Pittsburgh, PA
CfPIE's Effective Laboratory Safety Management
May 12–13 , 2008
Location | Malvern, PA
CfPIE's Current Good Laboratory Practices
May 12–14 , 2008
Location | Dublin, Ireland
Lorraine Marchand
- Clinilabs' new chief operating office.
Helen Jenkinson
- ACM Pivotal's new UK-based senior clinical laboratory scientist.
Holly Smith
- New director of Profect Medical Technologies' Clinical Imaging Services
Want to peer more into the future of the lab's impact on drug development? This opinion from Tepnel Research Products and Services is about the use of genotyping.
The WSJ Health Blog explores LabCorp's view of genetic diagnostic tests and its importance to the future of drug development.
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.
To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
